// App-Quantinova.ai

56 : Suppression of 6-Phosphofructo-2-Kinase (PFKFB3) for the treatment of breast cancer

Researchers

Presenter

  • Yoannis Imbert-Fernandez

Principal Investigators

  • Amy Clem

  • Brian Clem

  • Gilles Tapolsky

  • Sucheta Telang

  • Jason Chesney

Medical Centers

  • The University of Louisville, Louisville, KY

  • Advanced Cancer Therapeutics, Louisville, KY.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Retinoblastoma

  • Solid malignancies

Biomarkers

  • Cyclin-dependent kinase 4

  • 6-Phosphofructo-2-Kinase

Drug/Treatment

  • Fulvestrant

  • Palbociclib

  • Alora

  • Estrogens

  • PFK158

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved